HSV-1 and Alzheimer’s Disease: more than a hypothesis

HSV-1 and Alzheimer’s Disease: more than a hypothesis

Among the multiple factors concurring to Alzheimer’s Disease (AD) pathogenesis, greater attention should be devoted to the role played by infectious agents. Growing epidemiological and experimental evidence suggests that recurrent herpes simplex virus type-1 (HSV-1) infection is a risk factor for AD...

Full description

Bibliographic Details
Main Authors:	Roberto ePiacentini, Giovanna eDe Chiara, Domenica Donatella Li Puma, Cristian eRipoli, Maria Elena Marcocci, Enrico eGaraci, Anna Teresa Palamara, Claudio eGrassi
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2014-05-01
Series:	Frontiers in Pharmacology
Subjects:	Amyloid beta-Peptides Alzheimer's disease gamma-secretase HSV-1 recurrent infection
Online Access:	http://journal.frontiersin.org/Journal/10.3389/fphar.2014.00097/full

Similar Items

Herpes Simplex Virus-type1 (HSV-1) Impairs DNA Repair in Cortical Neurons
by: Giovanna De Chiara, et al.
Published: (2016-10-01)

Recurrent Herpes Simplex Virus Type 1 (HSV-1) Infection Modulates Neuronal Aging Marks in In Vitro and In Vivo Models
by: Giorgia Napoletani, et al.
Published: (2021-06-01)

APP processing induced by herpes simplex virus type 1 (HSV-1) yields several APP fragments in human and rat neuronal cells.
by: Giovanna De Chiara, et al.
Published: (2010-11-01)

Matriptase cleaves the amyloid-beta peptide 1–42 at Arg-5, Lys-16, and Lys-28
by: Li-Mei Chen, et al.
Published: (2019-01-01)

The Inhibition of DNA Viruses by the Amphibian Antimicrobial Peptide Temporin G: A Virological Study Addressing HSV-1 and JPCyV
by: Maria Elena Marcocci, et al.
Published: (2022-06-01)

Homer2 and Homer3 interact with amyloid precursor protein and inhibit Aβ production
by: Loukia Parisiadou, et al.
Published: (2008-06-01)

Multiple Herpes Simplex Virus-1 (HSV-1) Reactivations Induce Protein Oxidative Damage in Mouse Brain: Novel Mechanisms for Alzheimer’s Disease Progression
by: Virginia Protto, et al.
Published: (2020-06-01)

Expression of Amyloid Precursor Protein, Caveolin-1, Alpha-, Beta-, and Gamma-Secretases in Penumbra Cells after Photothrombotic Stroke and Evaluation of Neuroprotective Effect of Secretase and Caveolin-1 Inhibitors
by: Svetlana Sharifulina, et al.
Published: (2022-10-01)

Herpes Simplex Virus Mistyping due to HSV-1 × HSV-2 Interspecies Recombination in Viral Gene Encoding Glycoprotein B
by: Amanda M. Casto, et al.
Published: (2020-08-01)

Alzheimer’s disease: pathogenesis, diagnostics, and therapeutics
by: Tiwari S, et al.
Published: (2019-07-01)

Constitutive α- and β-secretase cleavages of the amyloid precursor protein are partially coupled in neurons, but not in frequently used cell lines
by: Alessio Colombo, et al.
Published: (2013-01-01)

Soluble Gamma-secretase Modulators Attenuate Alzheimer's β-amyloid Pathology and Induce Conformational Changes in Presenilin 1
by: Frank Raven, et al.
Published: (2017-10-01)

Modelling Alzheimer’s disease: from past to future
by: Claudia eSaraceno, et al.
Published: (2013-06-01)

he amyloid hypothesis of Alzheimer's disease: past and present, hopes and disappointments
by: I. V. Litvinenko, et al.
Published: (2019-11-01)

Cellular basis of Alzheimer′s disease
by: Bali Jitin, et al.
Published: (2010-10-01)

Cholesterol-dependent amyloid β production: space for multifarious interactions between amyloid precursor protein, secretases, and cholesterol
by: Vladimir Rudajev, et al.
Published: (2023-09-01)

Targeting Amyloidogenic Processing of APP in Alzheimer’s Disease
by: Jing Zhao, et al.
Published: (2020-08-01)

Gamma-secretase modulators: a promising route for the treatment of Alzheimer's disease
by: Gunnar Nordvall, et al.
Published: (2023-10-01)

Stress Hormones Epinephrine and Corticosterone Selectively Reactivate HSV-1 and HSV-2 in Sympathetic and Sensory Neurons
by: Poorna Goswami, et al.
Published: (2022-05-01)

Does Impairment of Adult Neurogenesis Contribute to Pathophysiology of Alzheimer's Disease? A Still Open Question
by: Domenica Donatella Li Puma, et al.
Published: (2021-01-01)

Alzheimer’s Disease: Background, Current and Future Treatments
by: Evelyn Chou
Published: (2014-06-01)

Anti-herpetic Activity of Macrocystis pyrifera and Durvillaea antarctica Algae Extracts Against HSV-1 and HSV-2
by: Estefanía Castillo, et al.
Published: (2020-09-01)

Abeta(1–40)-induced secretion of matrix metalloproteinase-9 results in sAPPα release by association with cell surface APP
by: Argiris A. Talamagas, et al.
Published: (2007-12-01)

Clinical evaluation of the Simplexa HSV 1 & 2 Direct assay for bronchoalveolar lavage specimens
by: Tung Phan, et al.
Published: (2024-06-01)

A Trivalent HSV-2 gC2, gD2, gE2 Nucleoside-Modified mRNA-LNP Vaccine Provides Outstanding Protection in Mice against Genital and Non-Genital HSV-1 Infection, Comparable to the Same Antigens Derived from HSV-1
by: Kevin P. Egan, et al.
Published: (2023-06-01)

HSV-1 latent rabbits shed viral DNA into their saliva
by: Hill James M, et al.
Published: (2012-09-01)

“Non-Essential” Proteins of HSV-1 with Essential Roles In Vivo: A Comprehensive Review
by: Christos Dogrammatzis, et al.
Published: (2020-12-01)

Neurotoxic effects induced by the Drosophila amyloid-β peptide suggest a conserved toxic function
by: Katia Carmine-Simmen, et al.
Published: (2009-02-01)

Molecular mechanism of the intramembrane cleavage of the β-carboxyl terminal fragment of amyloid precursor protein by γ-secretase
by: Maho eMorishima-Kawashima
Published: (2014-11-01)

The Large Ectodomain of APP Prevents APP from being Directly Cleaved by γ-Secretase
by: Yuan Li, et al.
Published: (2024-02-01)

Neuroprotective Activity of <i>Mentha</i> Species on Hydrogen Peroxide-Induced Apoptosis in SH-SY5Y Cells
by: Doaa M. Hanafy, et al.
Published: (2020-05-01)

HSV-1 Triggers an Antiviral Transcriptional Response during Viral Replication That Is Completely Abrogated in PKR<sup>−/−</sup> Cells
by: Rosamaria Pennisi, et al.
Published: (2023-09-01)

HSV-1 Oncolytic Viruses from Bench to Bedside: An Overview of Current Clinical Trials
by: Marilin S. Koch, et al.
Published: (2020-11-01)

Alzheimer’s Disease: Current and Future Treatments. A Review
by: Evelyn Chou
Published: (2014-05-01)

The prevalence of HSV2 antibodies in blood donors in city of Kerman During the Year 2002
by: S.M.A Arabzadeh, et al.
Published: (2003-12-01)

Proximity ligation assay reveals both pre- and postsynaptic localization of the APP-processing enzymes ADAM10 and BACE1 in rat and human adult brain
by: Jolanta L. Lundgren, et al.
Published: (2020-02-01)

Early administration of RS 67333, a specific 5-HT4 receptor agonist, prevents amyloidogenesis and behavioral deficits in the 5XFAD mouse model of Alzheimer’s disease
by: Patrizia eGiannoni, et al.
Published: (2013-12-01)

A potential anti-HIV-1 compound, Q308, inhibits HSV-2 infection and replication in vitro and in vivo
by: Xin Zhang, et al.
Published: (2023-06-01)

Enhancement of Herpes Simplex Virus (HSV) Infection by Seminal Plasma and Semen Amyloids Implicates a New Target for the Prevention of HSV Infection
by: Lilith Torres, et al.
Published: (2015-04-01)

Deciphering human cell-autonomous anti-HSV-1 immunity in the central nervous system
by: Fabien Gilbert Lafaille, et al.
Published: (2015-05-01)